BRISTOL-MYERS' FENOFIBRATE CLEARS FDA ADVISORY COMMITTEE FOR NARROW INDICATION: PATIENTS WITH HYPERTRIGLYCERIDEMIA AT RISK OF PANCREATITIS

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".